1
|
Pearson D, Garnier M, Luneau A, James AD, Walles M. 19F-NMR-based determination of the absorption, metabolism and excretion of the oral phosphatidylinositol-3-kinase (PI3K) delta inhibitor leniolisib (CDZ173) in healthy volunteers. Xenobiotica 2018; 49:953-960. [DOI: 10.1080/00498254.2018.1523488] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- David Pearson
- Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
| | - Maxime Garnier
- Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
| | - Alexandre Luneau
- Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
| | - Alexander David James
- Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
| | - Markus Walles
- Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
| |
Collapse
|